First, with the exception of a study in which PAI-1 levels were measured in 840 patients with severe sepsis enrolled in the PROWESS trial [36], the current report includes the largest cohort of sepsis patients analyzed to date for soluble markers of endothelial activation. This evidence concerns the gene SERPINE1 and Sepsis.